On a Mission to Transform Early Cardiac Diagnostics
Introducing CADScor®System- an advanced acoustic-based diagnostic aid to easily and quickly rule out significant coronary artery disease at point of care.*
Use CADScor®System to Rule-Out Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*
Non-invasive and radiation-free assessment for early rule-out of significant CAD
Can help save costs of more advanced CAD diagnostics in up to 35% of patients¹
Rapid and easy to use, with clear results at point of care
Quickly and easily rule-out significant CAD with at least 96% Confidence (Negative Predictive Value) ¹
CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze the patient’s coronary blood flow. The system calculates a patient-specific CAD-score, and couples it with risk factors to rapidly indicate the patient’s risk of significant coronary stenosis for immediate risk stratification, prior to potential secondary evaluation.1 CADScor®System has been used in over 40,000 patient assessments2 and has CE-marking and FDA De Novo clearance.
Physicians’ Experiences Using CADScor®System
Schedule a Demo of CADScor®System
Schedule a free demo of CADScor® System and learn how to quickly and easily rule out significant CAD in symptomatic patients at point of care.*
Latest Press Releases
Acarix AB’s Årsredovisning 2024
Acarix AB’s Annual Report 2024
KALLELSE TILL ÅRSSTÄMMA I Acarix AB
- User manual US-FDA v.12.Y, prevalence 10,7%
- Based on commercial patch use since 2017
*Rule-out with at least 96% confidence (NPV)